Auditory Cueing
DeviceAuditory cueing set at different frequency rates
NCT Number: NCT02666560
To determine the clinical efficacy of auditory cueing using a cross over design to investigate whether increasing auditory cueing frequency by 20% above self paced cadence affects gait parameters in children with Cerebral Palsy when performing a functional task.
Looking for future studies?
Notify Me5 year–11 year
All sexes
Interventional
Not applicable
Introduction: Cerebral Palsy is a non progressive disorder occurring in early brain development, resulting in inefficient ambulatory pattern. The use of sensory cues to facilitate loco-motor activity has been suggested as providing the necessary trigger to synchronise movement with greater beneficial outcomes observed at higher frequency intensities within the adult population. Thus auditory cueing could have the potential to alter gait parameters during a functional task.
Aim: To explore if increasing auditory cueing frequency (AC20) affects gait during a functional task compared to auditory cueing at self-paced cadence (ACSC).
Method: Nineteen children with CP levels 1 and 2 on the Gross Motor Function Classification Scale participated using paired analysis. Outcomes were compared to the mean values for temporal spatial gait data within the conditions using a cross over design. TS data was obtained by using the GAITRite® walkway system whilst walking holding a cup.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Auditory cueing set at different frequency rates
Time frame: Data was collected at a single time point for each condition. Conditions occurred within a two week time period.
The Gaitrite is a portable gait analysis walk-way system that enables the temprospatial measures of gait to be recorded. The temprospatial measure of length was recorded in centimetres.
Time frame: Data was collected at a single time point for each condition. Conditions occurred within a two week time period.
The Gaitrite is a portable gait analysis walk-way system that enables the temprospatial measures of gait to be recorded. The temprospatial measure of velocity was recorded in cm's per second.
Time frame: Data was collected at a single time point for each condition. Conditions occurred within a two week time period.
The Gaitrite is a portable gait analysis walk-way system that enables the temprospatial measures of gait to be recorded. The temprospatial measure of step time was recorded in seconds.
Time frame: Data was collected at a single time point for each condition. Conditions occurred within a two week time period.
The Gaitrite is a portable gait analysis walk-way system that enables the temprospatial measures of gait to be recorded. The temprospatial measure of cadence was recorded in steps per minute.
Time frame: Data was collected at a single time point for each condition. Conditions occurred within a two week time period.
The Gaitrite is a portable gait analysis walk-way system that enables the temprospatial measures of gait to be recorded. This was record in percentage of time spent in double support (%).
Time frame: Data was collected at a single time point for each condition. Conditions occurred within a two week time period.
The Gaitrite is a portable gait analysis walk-way system that enables the temprospatial measures of gait to be recorded. This was record in percentage of time spent in double support (%).
Institute of Child Health
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02364856
Brain Damage, Chronic, Brain Diseases
Lille, France
View Trial DetailsNCT06667518
Brain Damage, Chronic, Brain Diseases
Lamia, Phthiotis, Greece
View Trial DetailsNCT02918890
Behavior, Brain Damage, Chronic
New York, United States
View Trial DetailsNCT03818152
Brain Damage, Chronic, Brain Diseases
Ghent, Belgium
View Trial Details